White House’s $215M precision medicine initiative ushers in new era in healthcare

The White House announced that it is pumping $215 million into federal health and science agencies so they can develop infrastructure that allows data to flow between medical clinics to labs that sequence the human genome and gather other data, reports Politico.

The Precision Medicine Initiative, first mentioned in President Obama’s State of the Union Address, ultimately seeks to find more targeted personalized approaches to treatments and cures, according to the story.

Read more below:

Around the web

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries.